Clinical Trial Update: Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial updates show Phase 2 and Phase 3 testing of topical lidocaine to reduce pain in diabetic peripheral neuropathy; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Lidocaine (topical) (Lidocaine)

Snippet

Sponsor: Albany Medical College | Conditions: Diabetic Peripheral Neuropathy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-06-11